Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
uniQure shares climbed 36% after reports that Vinay Prasad, head of the FDA’s division of vaccines and gene therapies, will leave the agency next month to return to academia. The move triggered analyst upgrades for uniQure and broader rallies among gene therapy and rare disease stocks, with REGENXBIO up 13% and Biohaven rising 23%. Several analysts…
Altimmune President and CEO Jerome Benedict Durso acquired 20,000 shares of the company on March 6, 2026, paying a weighted average of $3.5395 per share for a total of $70,790. The purchase occurred while the stock traded near $3.54 after a 15% decline over the prior week. The company recently reported fourth-quarter 2025 results that missed expect…
Indonesia's Communications and Digital Ministry has distributed a ministerial regulation that directs platforms to deactivate social media accounts deemed 'high risk' for users under 16, effective March 28. Platforms named by the ministry include Roblox, Instagram, YouTube and TikTok. Company spokespeople said they are reviewing the rule and engagi…
The British pound has strengthened against the dollar over the past month despite domestic economic challenges, with Bank of America attributing the move to shifts in terms of trade, portfolio positioning and energy-sector flows rather than a sudden improvement in underlying fundamentals. Analysts note a break in the historical relationship between…
UBS warns that a sharp jump in energy costs following the Iran war has created simultaneous upward pressure on inflation and a drag on growth, complicating the European Central Bank's policy path. Markets have repriced expectations toward cumulative rate increases by December 2026, and UBS expects the ECB to present multiple scenarios at its March …
Markets have sharply repriced expectations for central bank policy after the Iran war elevated oil prices and the risk of sustained supply disruption. Investors now see the European Central Bank, the Swiss National Bank and Sweden's Riksbank moving to raise rates this year, with the Bank of England pushed back into the tightening conversation for 2…
Xenon Pharmaceuticals shares climbed 40% after topline results from the Phase 3 X-TOLE2 trial showed azetukalner significantly reduced focal onset seizure frequency versus placebo, meeting both primary and key secondary endpoints in two dose groups. The company plans to submit a New Drug Application in the third quarter of 2026.
U.S. stock futures fell sharply Monday after escalation in the Middle East conflict pushed energy prices higher, stoking worries about future economic growth. In premarket action a range of companies moved decisively: Hims & Hers and several smaller biotech and specialty companies jumped, while established drugmakers and life-science suppliers dipp…
Korro Bio Inc. (NASDAQ:KRRO) said on Monday it has secured an oversubscribed $85 million private investment in public equity (PIPE) financing, led by Venrock Healthcare Capital Partners. The financing, which prompted a 17% intraday gain for KRRO shares, will combine with the company's existing cash and marketable securities to extend its cash runwa…
Mojtaba Khamenei assumed Iran’s highest clerical role after state media showed street-level celebrations, but interviews with members of the Basij militia, ordinary citizens and analysts indicate his backing is narrower than the Islamic Republic has historically enjoyed. Amid U.S. and Israeli airstrikes that killed his father more than a week ago, …
Shares of Precision BioSciences (NASDAQ:DTIL) rose after the U.S. Food and Drug Administration awarded Fast Track status to PBGENE-DMD, the company's in vivo gene editing candidate for Duchenne muscular dystrophy. The designation is intended to streamline development and review, and follows IND clearance and plans for a Phase 1/2 study named FUNCTI…
U.S. stock indexes finished the week lower as a steep rise in oil prices and weaker-than-expected February jobs data weighed on sentiment. The Dow dropped about 0.95%, the S&P 500 fell 1.33% and the Nasdaq declined 1.59% on Friday. WTI crude climbed above $90 a barrel and registered roughly a 35% weekly gain - its largest since futures began tradin…
Applied Optoelectronics said it has won its first volume order for 1.6T data center transceivers from a major hyperscale customer, an initial commitment valued at more than $200 million. The company expects shipments to begin early in the third quarter of 2025 and to complete deliveries in the fourth quarter of this year, following product qualific…
Nvidia remains the dominant AI hardware franchise, but an elevated valuation, a narrowing market that is losing breadth, and clear technical/flow stress have combined to limit near-term upside. This trade idea lays out a mid-term short targeting $150 with a stop at $188 and a clear rationale tied to fundamentals, market positioning, and technical s…
Barclays analyst Jonathan Miller says recent U.S. data has reduced uncertainty around growth and the labour market, but rising oil prices represent the principal upside risk to inflation. The bank retains forecasts for two 25 basis-point rate cuts in June and December, while raising its December 2026 CPI projection following recent energy market mo…
Altimmune Chief Financial Officer Gregory L. Weaver bought 5,000 shares of company common stock on March 6, 2026, spending $17,700 at $3.54 per share. The purchase comes as the stock has slipped nearly 15% over the prior week and is trading nearer its 52-week low of $2.90 than its high of $7.73. Recent fourth-quarter 2025 results showed a wider-tha…
Vertiv, Lumentum and EchoStar recorded intraday gains after S&P Dow Jones Indices announced their inclusion in the S&P 500, with Coherent also named to join. The additions take effect before the open on March 23 as part of the quarterly reconstitution, which will push four other companies into the S&P SmallCap 600 and alter the S&P 100 membership.
American Bitcoin Corp. director Richard Busch acquired 68,000 shares on March 5, 2026, paying $1.15 per share for a total of $78,200, according to a Form 4 filing. The purchase comes while ABTC shares trade close to a 52-week low and follows a quarter that showed revenue growth alongside a net loss influenced by non-cash fair value adjustments. The…
Bank of America says rapid advances in generative AI are creating a major challenge for the software sector, even as startups post eye-catching ARR gains. Anthropic’s annualised recurring revenue reached $19 billion in early March, up 110% from $9 billion at end-2025, a surge that coincided with a $30 billion Series G and a $380 billion valuation. …
Relmada Therapeutics' stock climbed 25% after the company published 12-month interim results from its Phase 2 study of NDV-01 in high-risk non-muscle invasive bladder cancer. The data show strong complete response rates and no progression to muscle-invasive disease. Relmada outlined plans to begin a registrational Phase 3 program in mid-2026 and an…
Shares of Aureus Greenway Holdings jumped sharply after reports that the company will merge with Powerus, a West Palm Beach drone manufacturer supported by Eric Trump and Donald Trump Jr. The planned reverse merger would list Powerus on the Nasdaq in coming months and is positioned against growing U.S. interest in domestic drone suppliers.
Reports say finance ministers from the Group of Seven economies are set to discuss tapping strategic petroleum reserves to alleviate supply strains created by the ongoing conflict in Iran. The escalation has sent Brent and WTI crude surging above $100 per barrel, rattling global equities and prompting concerns about shipping, insurance and upstream…
A federal judge has determined that Kari Lake was not lawfully serving as acting CEO of the U.S. Agency for Global Media during much of 2025, voiding a set of decisions she made to reduce staff and curtail Voice of America operations. The ruling, delivered March 7, favors VOA journalists and a federal employees union and could upend cuts that remai…
Futures tied to Canada’s primary equity gauge fell on March 9 as intensifying conflict in the Middle East pushed oil to multi-year highs and heightened investor concern about inflation. March S&P/TSX composite futures were down roughly 0.92% early Monday, while Wall Street futures also moved lower. The escalation followed a high-profile political a…
Crude oil surged above $100 per barrel as the conflict in the Middle East entered its second week, driving U.S. pump prices above $3 per gallon and reigniting concerns about inflation amid weak U.S. labor data. Markets across bonds and equities fell sharply, while policymakers face pressure over strategic reserve releases and how to respond to the …
